A global, values-based, R&D-driven biopharmaceutical leader focused on innovation and patient care, with a strong U.S. presence and a legacy of over 235 years in advancing health solutions.
Boston
Cambridge
Massachusetts
Notice Date
March 25, 2026
July 1, 2026
December 31, 2027
Unavailable
More WARN Notices from
